Publications SOMA.CK

  • Why symptom burden in non-dialysis CKD matters.
    Shedden-Mora M, Jessen B, Huber T.
    American Journal of Kidney Diseases 2024; 84(6), 672–673. doi:10.1053/j.ajkd.2024.07.005

    Find the publication here

    Predictors of somatic symptom persistencein patients with chronic kidney disease(SOMA.CK): study protocol for a mixed-methods cohort study.
    Shedden-Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Rösch M, Dannenmeyer H, Gloy J, Van den Bergh O, Huber T.
    BMJ Open 2022;12:e067821. doi:10.1136/bmjopen-2022-067821

    Find the publication here

  • Somatic symptom disorder: a scoping review on the empirical evidence of a new diagnosis.
    Löwe B, Levenson J, Depping M, Husing P, Kohlmann S, Lehmann M, Shedden-Mora M, Toussaint A, Uhlenbusch N, Weigel A.
    PSYCHOL MED. 2021:1-17.

    Find the publication here

    Early psychological interventions for somatic symptom disorder and functional somatic syndromes: a systematic review and meta-analysis.
    Berezowski L, Ludwig L, Martin A, Löwe B, Shedden-Mora MC.
    PSYCHOSOMATIC MEDICINE. 2021; Online ahead of print.

    Find the publication here

    Development of the generic, multidimensional Treatment Expectation Questionnaire (TEX-Q) through systematic literature review, expert surveys and qualitative interviews.
    Alberts J, Löwe B, Glahn MA, Petrie KJ, Laferton J, Nestoriuc Y, Shedden-Mora MC.
    BMJ OPEN. 2020;10:e036169.

    Find the publication here

    SARS-CoV-2-renal tropism is associated with disease severity and acute kidney injury.
    Braun F, Luetgehetmann M, Pferfferle S, Wong M, Carsten A, Lindenmeyer M, Noerz, D, Heinrich F, Meißner K, …, Huber TB.
    LANCET. 2020: August 17.

    Find the publication here

    Multiorgan and Renal Tropism of SARS-CoV-2.
    Puelles VG, Lütgehetmann M, Lindenmeyer MT, Sperhake JP, Wong MN, Allweiss L, Chilla S, Heinemann A, Wanner N, …, Huber TB.
    N ENGL J MED. 2020: May 13.

    Find the publication here

    Stepped, collaborative, coordinated care for somatic symptom and related disorders (Sofu-Net) - A mixed-methods evaluation among health care professionals.
    Shedden-Mora MC, Kuby A, Tönnies J, Piontek K, Löwe B.
    ZEITSCHRIFT FÜR PSYCHOLOGIE. 2020;228(2):119-29.

    Find the publication here

    Optimizing expectations about cancer treatment: Results of the randomized controlled PSY-BREAST trial.
    Shedden-Mora MC, Pan Y, Heisig SR, Blanckenburg Pv, Rief W, Witzel I, Albert U-S, Nestoriuc Y. CLINICAL PSYCHOLOGY IN EUROPE. 2020;2(1):e2695.

    Find the publication here

    ARP3 Controls the Podocyte Architecture at the Kidney Filtration Barrier.
    Schell C, Sabass B, Helmstaedter M, Geist F, Abed A, Yasuda-Yamahara M, Sigle A, Maier JI, Grahammer F, …, Huber TB.
    DEV CELL. 2018:47(6):741-757.e8.

    Find the publication here

    Patients’ expectations regarding medical treatment: a critical review of concepts and their assessment.
    Laferton JAC, Kube T, Salzmann S, Auer CJ, Shedden-Mora MC.
    FRONT PSYCHOL. 2017;8(233).

    Find the publication here

    Effectiveness of a stepped, collaborative, and coordinated health care network for somatoform disorders (Sofu-Net): A controlled cluster cohort study.
    Löwe B, Lau K, Daubmann A, Härter M, Wegscheider K, König H-H, Shedden-Mora MC.
    PSYCHOSOM MED. 2017;79(9):1016-24.

    Find the publication here

    The FERM protein EPB41L5 regulates actomyosin contractility and focal adhesion formation to maintain the kidney filtration barrier.
    Schell C, Rogg M, Suhm M, Helmstädter M, Sellung D, Yasuda-Yamahara M, Kretz O, Kättner V, Suleiman H, …, Huber TB.
    PROC NATL ACAD SCI USA 2017:114(23):E4621-E4630.

    Find the publication here

    mTORC2 critically regulates renal potassium handling.
    Grahammer F, Nesterov V, Ahmed A, Steinhardt F, Sandner L, Arnold F, Cordts T, Negrea S, Bertog M, …, Huber TB.
    J CLIN INVEST. 2016;126(5):1773-82.

    Find the publication here

  • Symptom perception in chronic kidney disease – an expert survey among nephrologists (SOMA.CK study)
    Jessen B, Schmidt-Lauber C, Huber T, Löwe B, Shedden Mora M.
    European Association of Psychosomatic Medicine, 12.-15. June 2024, Lausanne.
    [Poster]

    Do patients with a chronic kidney disease perceive more symptoms after negative affect induction? An experimental study.
    Jessen B, Schmidt-Lauber C, Huber T, Löwe L, Shedden Mora M.
    European Association of Psychosomatic Medicine, 15.-17. June 2023, Wroclaw.
    [Lecture, 16. June 2023]

    Symptomwahrnehmung nach negativer Affektinduktion bei Patient:innen mit chronischer Nierenerkrankung - eine experimentelle Studie
    [Symptom Perception Following Negative Affect Induction in Patients with Chronic Kidney Disease – An Experimental Study]
    Jessen B, Schmidt-Lauber C, Huber TB, Löwe B, Shedden Mora M.
    German Congress for Psychotherapy, 10.-13. May 2023, Berlin.
    [Poster]

    Prädiktoren für die Persistenz somatischer Symptome bei Patient:innen mit chronischer Nierenerkrankung: SOMACROSS Projekt 3
    [Predictors of Symptom Persistence in Patients with Chronic Kidney Disease: SOMACROSS Project 3]
    Shedden Mora M, Jessen B, Schmidt-Lauber C, Huber T.
    German Congress for Psychosomatic Medicine and Psychotherapy, 22.-24. June 2022, Berlin.
    [Lecture, 23. June 2022]

    Predictors of Somatic Symptom Persistence in Patients with Chronic Kidney Disease (SOMA.CK). Project 3 of the SOMACROSS research unit
    Shedden Mora M, Jessen B, Schmidt-Lauber C, Löwe B, Huber T.
    European Association of Psychosomatic Medicine, 08.-11. June 2022, Vienna.
    [Lecture, 11. June 2022]